Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01859143 · ClinicalTrials.gov registry record · Phase 4
Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults
A Phase 4 study, sponsored by MedImmune.
- Completed
- Registry status
- Phase 4
- Development phase
- 300
- Enrollment target
NCT01859143 is a Phase 4 study that has completed, run by MedImmune. The registered enrollment target is 300 participants.
The verdict
NCT01859143, a Phase 4 study, has completed, sponsored by MedImmune.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 300 participants
- Enrollment target
Study Summary
This prospective annual release study is designed to evaluate the safety on new influenza virus vaccine strains to be included in FluMist Quadrivalent for the 2013-2014 influenza season.
Interventions
- OTHER Placebo
- BIOLOGICAL Trivalent Influenza Vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2013-05 |
| Est. Completion | 2013-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01859143
The ClinicalTrials.gov registry entry for NCT01859143 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedImmune, which has 210 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01859143 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01859143 about?
NCT01859143 is a clinical study titled "Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults". This prospective annual release study is designed to evaluate the safety on new influenza virus vaccine strains to be included in FluMist Quadrivalent for the 2013-2014 influenza season.
What is the current status of trial NCT01859143?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 300 participants. The study started on 2013-05. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01859143?
The interventions under investigation include: Placebo (OTHER), Trivalent Influenza Vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT01859143?
This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.